The oriGen case and Mexico's regulatory blind spots in genomic biobanking.
Medicine
Abstract
The oriGen project represents a pioneering but institutionally anchored response to Mexico's regulatory gap. Yet, viewed through the lens of contemporary scholarship, its model-private university ownership, broad individual consent, and external sequencing partnerships-stands in tension with emerging global norms for equitable, transparent, and democratically governed genomic research.